Ads
related to: target.comus.shein.com has been visited by 1M+ users in the past month
Search results
Ukraine claims it hit missile system inside Russian territory using Western weapons
CNN via Yahoo News· 43 minutes agoThe strike comes days after US President Joe Biden gave Ukraine permission to carry out limited...
Tesla shares hold steady as Piper Sandler maintains $205 target By Investing.com
Investing.com· 12 hours agoOn Monday, Piper Sandler maintained its price target for Tesla shares (NASDAQ:TSLA) at $205. This...
Shangri-La: As generals made small talk and polite debate, both China and Trump loomed large
CNN via Yahoo News· 2 hours agoNg warned, after invoking the Gaza and Ukraine conflicts. In this tense geopolitical environment,...
Target’s Pride Month collection will be in fewer stores
KTLA articles via Yahoo News· 11 hours agoTarget has limited the availability of its Pride merchandise after facing intense backlash from some...
Jefferies cuts Howard Hughes target to $80, retains 'buy' rating By Investing.com
Investing.com· 12 hours agoOn Monday, Jefferies made an adjustment to its financial outlook for Howard Hughes Holdings...
Cyclacel Pharmaceuticals maintains $11 target, Buy rating By Investing.com
Investing.com· 15 hours agoOn Monday, Roth/MKM maintained its Buy rating and $11.00 price target for Cyclacel Pharmaceuticals...
BofA raises Nvidia target to $1,500, sees EPS power of over $50 within 2 years By Investing.com
Investing.com· 22 hours agoBofA raises Nvidia target to $1,500, sees EPS power of over $50 within 2 years
RBC lifts Methanex shares target on price forecast By Investing.com
Investing.com· 21 hours agoOn Monday, RBC (TSX:RY) Capital Markets adjusted its outlook on Methanex (NASDAQ:MEOH) Corporation...
Science Applications stock target cut on modest growth outlook By Investing.com
Investing.com· 15 hours agoOn Monday, Stifel has adjusted the price target for Science Applications (NASDAQ:SAIC) International...
DexCom maintains $150 target amid new FDA approval By Investing.com
Investing.com· 14 hours agoOn Monday, Oppenheimer maintained its Outperform rating and $150.00 price target for DexCom...